Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
Kiniksa Pharmaceuticals International has initiated Heart’s Home™, a direct-to-consumer TV and digital campaign to increase awareness of recurrent pericarditis and encourage patients to discuss ARCALYST, the first and only FDA-approved therapy for this condition, with their healthcare providers. The campaign aims to expand the patient base and driv…